- Home » News and EventsPage 23
NEWS & EVENTS
Our newest offerings and capabilities. Recent investments in network capacity, new and expanded services and expertise. Upcoming conferences and events.
Catalent to Present Case Studies on Formulation Design for Early Phase Molecules and Discuss Benefits of Mass Spectrometry for HCP Analysis at AAPS PharmSci 360
Oct 24, 2019
Catalent today announced it will give two presentations during the “Manufacturing and Bioprocessing Track” at the forthcoming American Association of Pharmaceutical Scientists (AAPS) PharmSci 360 at the Henry B. Gonzalez Convention Center, San Antonio, Texas, on Nov. 3 – 6, 2019.
Catalent To Debate Logistics Of Delivery And Transportation Of Cell And Gene Therapies At HPCLC
Oct 22, 2019
Catalent today announced that Ann McMahon, Program Director, Clinical Supply Services and Drug Product Technologies Integration, will participate in a panel session titled “Cell and Gene Therapy Logistics” at the upcoming Health and Personal Care Logistics Conference (HPCLC), to be held at the Gwen Hotel, Chicago, on Oct. 28 – 30, 2019.
Catalent to Discuss Handling & Destruction of Returned Clinical Trial Materials
Oct 15, 2019
Catalent today announced that Mark Woolf, its Director of Depot Networks, will present at the upcoming 6th Annual Global Clinical Supplies Group European Knowledge Forum, to be held in Cascais, Portugal, on Oct. 22 – 24, 2019.
Catalent to Discuss the Benefits of ‘Ready-to-Market’ Formulations at SupplySide West
Oct 8, 2019
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products, today announced that it will present at the upcoming SupplySide West conference in Las Vegas.
Catalent Appoints Dr. Guy Dewil as General Manager
Oct 3, 2019
Catalent, a global leader in clinical supply services, today announced that Guy J. Dewil, M.D. has been appointed General Manager of its clinical supply facility in Schorndorf, Germany.
Catalent to Discuss How Drug Design Influences Patient Outcomes at PODD
Oct 2, 2019
Catalent today announced it will present at the 9th Partnership Opportunities in Drug Delivery (PODD) annual conference at the Renaissance Boston Waterfront Hotel, Boston, on Oct. 7 – 8, 2019.
Catalent Applied Drug Delivery Institute to Host Symposium on Smart Drug Development and Design
Sep 26, 2019
CADDI today announced that along with Columbia University’s Lab-to-Market Accelerator Network and the Translational Therapeutics Accelerator (TRx), it will co-host a one-day symposium titled “Smart Drug Development & Design” at Columbia University.
Catalent and Minerva Neurosciences Enter Commercial Supply Agreement for Schizophrenia Drug Roluperidone
Sep 24, 2019
Catalent and Minerva Neurosciences, Inc. today announced that they have entered into a long-term commercial supply agreement for roluperidone, an investigational compound for the treatment of schizophrenia.
Advantages of Singapore as a Clinical Supply Hub to be Discussed by Catalent at Accelerating Clinical Trials in Asia Conference
Sep 17, 2019
Catalent today announced that Julie Delaney, Director, Project and Clinical Supplies Management, Asia Pacific (APAC) will present at the upcoming 3rd Annual Accelerating Clinical Trials in Asia on Sept. 25 – 26, 2019.
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.